Back

Metabolic intervention with trimetazidine improves intracardiac hemodynamics in patients with advanced heart failure

11 May 2024 (16:00 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 2 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Syuzanna Shahnazaryan

Yerevan State Medical University Hospital 1: University Cardiology Clinic, Yerevan (Armenia)

7 More presentations in this session

Presentation thumbnail
Quality of care among patients with heart failure with reduced ejection fraction at an outpatient setting in a tertiary center
Doctor K. Enriquez (Manila, PH)
Abstract Slides Video
Presentation thumbnail
The difference in the use of guideline-directed medical therapy in patients hospitalised for heart failure managed by cardiologists and non-cardiologists
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video
Presentation thumbnail
Use of guideline-directed therapy in patients hospitalised at a general internal medicine ward
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video
Presentation thumbnail
Did we forget ARNI in the era of SGLTi?
Doctor T. Cikara (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure
Doctor H. Unlugenc (Izmir, TR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2024

11 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Changes in hemodynamic, strain and myocardial work parameters predict long term mortaility and rehospitalization in acute, decompensated heart failure after levosimendan administration.
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?
thumbnail
Congress Presentation
The effect of Trimetazidine on the left ventricular global longitudinal strain assessed by cardiac magnetic resonance in stable angina patients with previous myocardial infarction and left ventricular

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources